ATE410155T1 - Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung - Google Patents
Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlungInfo
- Publication number
- ATE410155T1 ATE410155T1 AT04701143T AT04701143T ATE410155T1 AT E410155 T1 ATE410155 T1 AT E410155T1 AT 04701143 T AT04701143 T AT 04701143T AT 04701143 T AT04701143 T AT 04701143T AT E410155 T1 ATE410155 T1 AT E410155T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- breast cancer
- cyclin
- cancer treatment
- treatment
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102000016736 Cyclin Human genes 0.000 title 1
- 108050006400 Cyclin Proteins 0.000 title 1
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 abstract 2
- 102000006311 Cyclin D1 Human genes 0.000 abstract 1
- 108010058546 Cyclin D1 Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229960001603 tamoxifen Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0300098A SE0300098D0 (sv) | 2003-01-15 | 2003-01-15 | Use of cyclin D1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE410155T1 true ATE410155T1 (de) | 2008-10-15 |
Family
ID=20290133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04701143T ATE410155T1 (de) | 2003-01-15 | 2004-01-09 | Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060019883A1 (de) |
| EP (1) | EP1583522B1 (de) |
| AT (1) | ATE410155T1 (de) |
| DE (1) | DE602004016950D1 (de) |
| SE (1) | SE0300098D0 (de) |
| WO (1) | WO2004062654A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1718280A4 (de) | 2004-01-30 | 2010-08-18 | Mars Inc | Verfahren und zusammensetzungen zur krebsbehandlung |
| EP1743654A1 (de) * | 2005-07-15 | 2007-01-17 | TopoTarget Germany AG | Verwendung von Histon Deacetylase-Hemmer zusammen mit NSAIDen zur Behandlung von Krebs und/oder Entzündungskrankheiten |
| EP1965824A4 (de) * | 2005-11-18 | 2011-10-19 | Gloucester Pharmaceuticals Inc | Metaboliten-derivate des hdac-inhibitors fk228 |
| CA2649877A1 (en) | 2006-04-24 | 2007-12-21 | Gloucester Pharmaceuticals | Gemcitabine combination therapy |
| WO2007146730A2 (en) | 2006-06-08 | 2007-12-21 | Gloucester Pharmaceuticals | Deacetylase inhibitor therapy |
| JP2010514801A (ja) | 2006-12-29 | 2010-05-06 | グラスター ファーマシューティカルズ， インコーポレイテッド | ロミデプシンの精製 |
| CA2674313A1 (en) * | 2006-12-29 | 2008-07-10 | Gloucester Pharmaceuticals, Inc. | Romidepsin-based treatments for cancer |
| WO2009088849A2 (en) * | 2008-01-04 | 2009-07-16 | Immune Disease Institute, Inc. | Treatment or prevention of inflammation by targeting cyclin d1 |
| BRPI0912682A2 (pt) * | 2008-05-16 | 2016-05-03 | Atlas Antibodies Ab | previsão de tratamento que envolve a proteína hmgcr |
| CA2769038A1 (en) * | 2009-07-31 | 2011-02-03 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Antiangiogenic small molecules and methods of use |
| MX342913B (es) | 2010-07-12 | 2016-10-19 | Celgene Corp * | Formas solidas de romidepsina y sus usos. |
| US8859502B2 (en) | 2010-09-13 | 2014-10-14 | Celgene Corporation | Therapy for MLL-rearranged leukemia |
| US20120208872A1 (en) * | 2011-02-11 | 2012-08-16 | Taipei Medical University | Use of tea polyphenols for treating and/or preventing nicotine or nicotine-derived compounds or estrogen induced breast cancer |
| TWI481398B (zh) * | 2011-02-14 | 2015-04-21 | Univ Taipei Medical | 茶多酚用於治療及／或預防尼古丁或尼古丁衍生化合物或雌激素誘發之乳癌之用途 |
| AU2013202506B2 (en) | 2012-09-07 | 2015-06-18 | Celgene Corporation | Resistance biomarkers for hdac inhibitors |
| AU2013202507B9 (en) | 2012-11-14 | 2015-08-13 | Celgene Corporation | Inhibition of drug resistant cancer cells |
| NZ630311A (en) | 2013-12-27 | 2016-03-31 | Celgene Corp | Romidepsin formulations and uses thereof |
| WO2023211888A1 (en) * | 2022-04-25 | 2023-11-02 | Delta Next-Gene, LLC | Methods of treating cancer by targeting drivers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410061B1 (en) * | 1999-03-30 | 2002-06-25 | Purdue Research Foundation | Tea catechins as cancer specific proliferation inhibitors |
-
2003
- 2003-01-15 SE SE0300098A patent/SE0300098D0/xx unknown
-
2004
- 2004-01-09 EP EP04701143A patent/EP1583522B1/de not_active Expired - Lifetime
- 2004-01-09 AT AT04701143T patent/ATE410155T1/de not_active IP Right Cessation
- 2004-01-09 WO PCT/SE2004/000006 patent/WO2004062654A1/en not_active Ceased
- 2004-01-09 DE DE602004016950T patent/DE602004016950D1/de not_active Expired - Fee Related
-
2005
- 2005-07-12 US US11/179,901 patent/US20060019883A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060019883A1 (en) | 2006-01-26 |
| WO2004062654A1 (en) | 2004-07-29 |
| DE602004016950D1 (de) | 2008-11-20 |
| EP1583522B1 (de) | 2008-10-08 |
| EP1583522A1 (de) | 2005-10-12 |
| SE0300098D0 (sv) | 2003-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004016950D1 (de) | Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| EA200801565A1 (ru) | Производные пиримидиниларилмочевины в качестве ингибиторов фактора роста фибробластов ( fgf-фактора ) | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| DE60030889D1 (de) | Verwendung von egfr tyrosine kinase hemmern zur behandlung von brustkrebs | |
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| CY1106386T1 (el) | Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης | |
| ATE312635T1 (de) | Ventilanordnung | |
| DE60118889D1 (de) | Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs | |
| DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
| BRPI0508700A (pt) | uso de sns-595, composição farmacêutica, e, pó liofilizado | |
| DE502004008819D1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| PH12021553102A1 (en) | Methods of treating fabry disease in patients having renal impairment | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| DE602004017326D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| EA201071422A1 (ru) | Способы лечения заболеваний, связанных с мейотическим кинезином | |
| CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης | |
| ATE353650T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| EA200700637A1 (ru) | Соли донепезила, подходящие для получения фармацевтических композиций | |
| SE0402507D0 (sv) | Medicinsk lösning, förfarande för framställning och användning därav | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| DK1653964T3 (da) | Cancerkombinationsterapi omfattende AZD2171 og ZD1839 | |
| ATE382347T1 (de) | Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol | |
| EA200702136A1 (ru) | Композиции станнсопорфина и их применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |